TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Visiopharm LRI AB
Closing information (x1000 EUR)
Closing information | 2024/09 | 2023/09 | 2022/09 |
Turnover |
1,787
|
2,290 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
77
|
216 | |
EBITDA |
65
|
216 | |
Total assets |
1,768
|
1,421 | |
Current assets |
1,766
|
1,421 | |
Current liabilities |
882
|
533 | |
Equity capital |
863
|
846 | |
- share capital |
9
![]() |
9 | |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Solvency |
48.8%
|
59.5% | |
Turnover per employee |
596
|
763 | |
Profit as a percentage of turnover |
4.3%
|
9.4% | |
Return on assets (ROA) |
4.4%
|
15.2% | |
Current ratio |
200.2%
|
266.6% | |
Return on equity (ROE) |
8.9%
|
25.5% | |
Change turnover |
-389
|
-391 | |
Change turnover % |
70%
|
-18%
|
-15% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.